Increased plasma urotensin II levels in patients with diabetes mellitus

Kazuhito Totsune, Kazuhiro Takahashi, Zenei Arihara, Masahiko Sone, Sadayoshi Ito, Osamu Murakami

Research output: Contribution to journalArticlepeer-review

172 Citations (Scopus)


Urotensin II (UII) is the most potent vasoconstrictor peptide, whereas it acts as a vasodilator on some arteries. We studied plasma levels of UII in diabetic patients with normal serum creatinine levels (< 90 μmol/l) and the expression of UII and its receptor in cultured human vascular endothelial cells. Plasma UII levels were significantly elevated by 1.8-fold in diabetic patients without proteinuria (7.8±0.6 fmol/ml; P < 0.0001) and 1.7-fold in those with overt proteinuria (7.3±0.9 fmol/ml; P = 0.0018) when compared with healthy subjects (4.4±0.2 fmol/ml). No significant correlation was obtained between plasma UII levels and fasting blood sugar (P = 0.631 and P = 0.853 in non-proteinuric and proteinuric diabetic patients respectively), glycated haemoglobin levels (P = 0.376 and P = 0.888 respectively) or serum creatinine levels (P = 0.301 and P = 0.568 respectively). Reverse transcriptase-PCR analysis showed the expression of mRNAs encoding UII precursor and UII-receptor precursors in cultured human coronary artery endothelial cells and umbilical vein endothelial cells, suggesting that vascular endothelial cells are one of the sources of UII in blood. These findings suggest that elevation of plasma UII levels may be an important background factor in diabetic cardiovascular and organ complications in diabetic subjects without renal failure.

Original languageEnglish
Pages (from-to)1-5
Number of pages5
JournalClinical Science
Issue number1
Publication statusPublished - 2003 Jan 1


  • Diabetes
  • Plasma
  • Reverse transcriptase-PCR
  • RIA
  • Urotensin II
  • Vascular endothelial cell


Dive into the research topics of 'Increased plasma urotensin II levels in patients with diabetes mellitus'. Together they form a unique fingerprint.

Cite this